Gamida Cell Ltd. - Ordinary Shares (GMDA): Price and Financial Metrics
GMDA Price/Volume Stats
| Current price | $0.03 | 52-week high | $2.51 |
| Prev. close | $0.04 | 52-week low | $0.03 |
| Day low | $0.03 | Volume | 23,036,800 |
| Day high | $0.04 | Avg. volume | 9,201,723 |
| 50-day MA | $0.32 | Dividend yield | N/A |
| 200-day MA | $0.76 | Market Cap | 5.04M |
GMDA Stock Price Chart Interactive Chart >
Gamida Cell Ltd. - Ordinary Shares (GMDA) Company Bio
Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
GMDA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -90.45% |
| 3-year | -98.74% |
| 5-year | -99.39% |
| YTD | -92.73% |
| 2023 | -68.01% |
| 2022 | -49.21% |
| 2021 | -69.73% |
| 2020 | 95.12% |
| 2019 | -56.74% |
Loading social stream, please wait...